Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
Andreozzi GM, Bignamini AA, Davì G, Palareti G, Matuška J, Holý M, Pawlaczyk-Gabriel K, Džupina A, Sokurenko GY, Didenko YP, Andrei LD, Lessiani G, Visonà A; SURVET Study Investigators. Andreozzi GM, et al. Among authors: bignamini aa. Circulation. 2015 Nov 17;132(20):1891-7. doi: 10.1161/CIRCULATIONAHA.115.016930. Epub 2015 Sep 25. Circulation. 2015. PMID: 26408273 Free PMC article. Clinical Trial.
Anticoagulation Duration After First Venous Thromboembolism: Real-Life Data From the International, Observational WHITE Study.
Palareti G, Bignamini AA, Cini M, Li YJ, Urbanek T, Madaric J, Bouslama K, Sokurenko GY, Andreozzi GM, Matuška J, Mansilha A, Barinov V. Palareti G, et al. Among authors: bignamini aa. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211049402. doi: 10.1177/10760296211049402. Clin Appl Thromb Hemost. 2021. PMID: 34841907 Free PMC article.
Unprovoked or provoked venous thromboembolism: not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries-the prospective, international, observational WHITE study.
Palareti G, Bignamini A, Cini M, Li YJ, Urbanek T, Madaric J, Bouslama K, Sokurenko GY, Andreozzi GM, Matuška J, Mansilha A, Barinov V; WHITE study group. Palareti G, et al. Intern Emerg Med. 2022 Jan;17(1):71-82. doi: 10.1007/s11739-021-02765-1. Epub 2021 Jul 27. Intern Emerg Med. 2022. PMID: 34313959 Free PMC article.
Influence of clinical presentation, site, and extent of venous thrombosis on decision about duration of anticoagulation: Data from the international, prospective, observational WHITE study.
Palareti G, Bignamini AA, Urbanek T, Cini M, Li YJ, Madaric J, Bouslama K, Sokurenko GY, Andreozzi GM, Matuška J, Mansilha A, Barinov V; WHITE study group. Palareti G, et al. Among authors: bignamini aa. Thromb Res. 2022 Mar;211:140-146. doi: 10.1016/j.thromres.2022.01.025. Epub 2022 Feb 4. Thromb Res. 2022. PMID: 35151009 Free article.
Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism.
Palareti G, Legnani C, Antonucci E, Zorzi S, Bignamini AA, Lodigiani C, Tosetto A, Bertù L, Pengo V, Testa S, Ageno W, Prisco D, Prandoni P, Poli D. Palareti G, et al. Among authors: bignamini aa. Intern Emerg Med. 2021 Mar;16(2):359-368. doi: 10.1007/s11739-020-02381-5. Epub 2020 May 25. Intern Emerg Med. 2021. PMID: 32451933 Free PMC article.
55 results